Raymond James Starts Avalyn Pharma (AVLN) at Outperform Oct 2, 2026 05:06AM
Avalyn Pharma presents AP01 lung distribution data at ERS 2026 Sep 8, 2026 08:04AM
Morgan Stanley Starts Avalyn Pharma (AVLN) at Overweight May 26, 2026 12:54AM
Jefferies Starts Avalyn Pharma (AVLN) at Buy May 25, 2026 10:31AM
Guggenheim Starts Avalyn Pharma (AVLN) at Buy May 25, 2026 10:13AM


May 21, 2026 08:03AM Avalyn to present 4-year data on inhaled pirfenidone at EULAR 2026
Apr 29, 2026 09:36AM Avalyn Pharma (AVLN) files for 16.67M share IPO at $16-$18/sh
Apr 8, 2026 04:05PM Avalyn Pharma files for Nasdaq IPO